MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Pharmacotherapy"

  • MDS Virtual Congress 2021

    Is past use of statins associated with lower incidence of Parkinson’s disease?

    TTH. Nguyen, A. Fournier, F. Artaud, E. Courtois, S. Escolano, P. Tubert-Bitter, MC. Boutron, G. Severi, E. Roze, I. Degaey, M. Canonico, I. Ahmed, A. Thiébaut, A. Elbaz (Villejuif, France)

    Objective: To examine the relation of past exposure to statins with Parkinson’s disease (PD) incidence. Background: Drug repurposing has recently emerged as a promising approach…
  • MDS Virtual Congress 2021

    Levodopa-Carbidopa Intestinal Gel Therapy for Advanced Parkinson’s Disease: A Single Center ‘Real World’ Study of Patients with and without DBS

    P. Dole, S. Green, M. Wiggins, J. Joseph, M. Gaspari, M. Siddiqui (Winston-Salem, USA)

    Objective: To examine the efficacy and safety of LCIG in a ‘real world’ tertiary care center setting in patients with and without DBS. Background: Levodopa-Carbidopa…
  • MDS Virtual Congress 2021

    Role of Selective Serotonin Reuptake Inhibitors in the Management of Motor Tics in Tourette’s Syndrome

    A. Armas-Salazar, J. Ortega-Márquez, D. Sandoval-Lopez, G. Pérez-Plascencia, C. Ortéga-Arenas, D. Chapa-Juárez (Ciudad de México, Mexico)

    Objective: Determine the usefulness of paroxetine in terms of motor and behavioral manifestations control in a patient with Tourrete Syndrome (TS) with intolerance to dopamine…
  • MDS Virtual Congress 2021

    Adherence to medication among Serbian Parkinson’s disease patients: a cross-sectional study

    A. Milovanović, B. Radojević, NT. Dragašević-Mišković, M. Svetel, I. Petrović, A. Tomić-Pešić, M. Savić, D. Stanisavljević, VS. Kostić (Belgrade, Serbia)

    Objective: This study aimed to explore patients’ adherence to antiparkinsonian medication, and to determine factors associated with low adherence among Serbian PD patients. Background: Adherence…
  • MDS Virtual Congress 2021

    TREMOR-LYTIC AND PREFRONTO-CORTICAL PROPERTIES OF Nigella sativa OIL IN PHENOL-INDUCED MICE MODELS OF ESSENTIAL TREMOR

    R. Folarin, O. Oyeleye, B. Surajudeen, O. Owoniyi, O. Omotosho, N. Asaye, E. Keshinro (Sagamu, Nigeria)

    Objective: This work assessed the tremor-lytic and prefronto-cortical properties of Nigella sativa oil in phenol-induced mice models of essential tremor. Background: Essential tremor is a…
  • MDS Virtual Congress 2021

    Evaluation of a double-target therapeutic in preclinical models of Parkinson’s disease

    FJ. Sanz, C. Solana-Manrique, E. Masià, MJ. Vicent, N. Paricio (Burjassot, Spain)

    Objective: To evaluate the effectiveness of a candidate compound identified in a high-throughput screening (HTS) assay carried out in a Drosophila model of Parkinson’s disease…
  • MDS Virtual Congress 2021

    Disparities in Access to Spasticity Chemodenervation Specialists in the United States: a National Analysis of Medicare Data

    R. Kazerooni, S. Healy, M. Verduzco-Gutierrez (Raleigh, USA)

    Objective: To explore the variations in access to spasticity chemodenervation specialists across several geographical, ethnic, racial, and population density factors. Background: Equity in access to…
  • MDS Virtual Congress 2021

    Problems faced by Parkinson’s disease patients during COVID-19 pandemic compulsory lockdown and its management with the help of Telemedicine in a North Indian cohort

    K. Shukla, N. Sawal (Chandigarh, India)

    Objective: To study problems faced by PD patients during lockdown due lack of healthcare and medication procurement and address such problems using telemedicine via virtual…
  • MDS Virtual Congress 2021

    Apomorphine Sublingual Film for “OFF” Episodes in Parkinson’s Disease: Impact on Impulse Control Disorders

    A. Espay, K. Markopoulou, I. Zhang, E. Pappert, B. Navia (Cincinnati, USA)

    Objective: Assess impact of apomorphine sublingual film (APL) on impulse control disorders (ICDs) in patients with Parkinson’s disease (PD) and “OFF” episodes. Background: In a…
  • MDS Virtual Congress 2021

    Beta-antagonists and risk of Parkinson’s disease: Meta-analysis of real-world evidence studies

    A. Singh, S. Hussain, B. Antony (Hobart, Australia)

    Objective: We performed a systematic review and meta-analysis of real-world evidence (RWE) studies evaluating the association between use of β-antagonist and the risk of PD.…
  • « Previous Page
  • 1
  • …
  • 14
  • 15
  • 16
  • 17
  • 18
  • …
  • 36
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley